bims-pideca Biomed News
on Class IA PI3K signalling in development and cancer
Issue of 2025–12–14
nineteen papers selected by
Ralitsa Radostinova Madsen, MRC-PPU



  1. Nat Commun. 2025 Dec 10.
      The vagus nerve (VN) is a major component of the parasympathetic nervous system that regulates glucose and energy homeostasis. However, the specific molecular signaling pathways within the VN that regulates this homeostasis remain unclear. Here, we show that vagal neuron-specific deletion of phosphatase and tensin homolog (Pten), the endogenous negative regulator of PI3K, led to increased vagal output. Intriguingly, dopaminergic signaling genes were upregulated, correlating with elevated sympathetic nerve density and increased norepinephrine levels in adipose tissue of vagal Pten-deficient mice. These mice were also protected against high-fat diet-induced obesity, insulin resistance, and systemic inflammation. To investigate insulin-specific PI3K signaling within the VN, we generated mice with vagal neuron-specific insulin receptor deletion that resulted in exacerbation of metabolic defects, which was rescued by concomitant Pten deletion. In summary, we show that insulin-PI3K-PTEN axis within vagal neurons is essential in optimizing the autonomic output that determines peripheral inflammatory and metabolic homeostasis.
    DOI:  https://doi.org/10.1038/s41467-025-67192-8
  2. Cell Rep. 2025 Dec 10. pii: S2211-1247(25)01436-6. [Epub ahead of print]44(12): 116664
      Tuberous sclerosis complex (TSC) is caused by variants in either TSC1 or TSC2, which cooperate to inhibit the mechanistic target of rapamycin complex 1 (mTORC1). TSC is associated with neurological disorders that are attributed to disinhibition of mTORC1, but the mechanisms connecting dysregulation of mTORC1 to molecular and physiological changes in neurons remain unclear. In this study, we aim to understand transcriptional changes in TSC and identify downregulation of the immediate-early gene EGR1 in TSC2-deficient excitatory neurons. Furthermore, we find that activity-dependent transcription is impaired in TSC due to abnormalities in maturation-dependent DNA demethylation. Finally, we determine that mTORC1 inhibition started late in neuronal maturation of human neurons is only partially effective in reversing gene expression changes and ineffective in reducing spontaneous neuronal hyperactivity in TSC. These data demonstrate a critical window in early brain development where mTORC1 dysregulation leads to transcriptional changes that contribute to persistent neuronal abnormalities.
    Keywords:  CP: molecular biology; CP: neuroscience; DNA methylation; activity-dependent transcription; mTOR complex 1; tuberous sclerosis complex
    DOI:  https://doi.org/10.1016/j.celrep.2025.116664
  3. STAR Protoc. 2025 Dec 05. pii: S2666-1667(25)00645-8. [Epub ahead of print]6(4): 104239
      The rapid and reliable generation of endothelial cells from induced pluripotent stem cells (iPSCs) is a keystone for biomedical research and regenerative medicine. Here, we present a protocol for human iPSC genetic engineering, ETS variant 2 (ETV2)-mediated endothelial differentiation, and subsequent injection in ex vivo mouse brain explants to study cellular interactions. By leveraging optimized techniques and tackling common technical problems, we provide a platform that enables physiologically relevant studies of vascular behavior, plasticity, and interactions within the neural microenvironment. For complete details on the use and execution of this protocol, please refer to Arce et al.1.
    Keywords:  cell biology; cell culture; cell differentiation; stem cells
    DOI:  https://doi.org/10.1016/j.xpro.2025.104239
  4. Vasc Biol. 2025 Dec 10. pii: VB-25-0015. [Epub ahead of print]
      Blood flow within the vasculature is a critical determinant of endothelial cell (EC) identity and functionality, yet the intricate interplay of various hemodynamic forces and their collective impact on endothelial and vascular responses are not fully understood. Specifically, the role of hydrostatic pressure in the EC flow response is understudied, despite its known significance in vascular development and disease. To address this gap, we developed in vitro models to investigate how pressure influences EC responses to flow. Our study demonstrates that elevated pressure conditions significantly modify shear-induced flow alignment and increase endothelial cell density. Bulk and single-cell RNA sequencing analyses revealed that, while shear stress remains the primary driver of flow-induced transcriptional changes, pressure modulates shear-induced signaling in a dose-dependent manner. These pressure-responsive transcriptional signatures identified in human ECs were conserved during the onset of circulation in early mouse embryonic vascular development, where pressure was notably associated with transcriptional programs essential to arterial and hemogenic EC fates. Our findings suggest that pressure plays a synergistic role with shear stress on ECs and emphasizes the need for an integrative approach to endothelial cell mechanotransduction, one that encompasses the effects induced by pressure alongside other hemodynamic forces.
    Keywords:  arterial fate; endothelial cells; flow response; hemodynamic pressure
    DOI:  https://doi.org/10.1530/VB-25-0015
  5. Nat Commun. 2025 Dec 06.
      Pairwise perturbation of gene function using the CRISPR/Cas9 system has potential in screening for genetic interactions and synthetic lethal gene pairs to identify combination therapies for cancer. However, existing dual guide expression systems are cumbersome to clone, often result in a large proportion of undesired guide pairs and have an imbalance of guide expression from the two positions. Here, we demonstrate a next-generation system for dual guide delivery based around a tRNA spacer that allows a single-step cloning strategy, as little as 2% of undesired guide pairs, and highly balanced expression of the two guides. This system allows efficient library-scale screening for hundreds of thousands of genetic interactions using the well-understood Streptococcus pyogenes Cas9 (SpCas9) system. We use this to screen a 100,136 guide pair library in colorectal cancer cells and successfully identify synthetic lethal genetic interactions between paralogs or other known interacting genes, establishing our method for performing efficient large-scale genetic interaction screens. This system is versatile and could be used with most guide RNA vector systems, and for other uses of paired guide delivery, such as improving single gene knockout efficiency or improving guide detection in single cell or optical CRISPR screens.
    DOI:  https://doi.org/10.1038/s41467-025-67256-9
  6. Mol Syst Biol. 2025 Dec 10.
      Functional genomics screens in human induced pluripotent stem cells (hiPSCs) remain challenging despite their transformative potential. We developed iPS2-seq: an inducible, clone-aware screening platform that enables phenotype-agnostic, single-cell resolved dissection of loss-of-function effects in hiPSC derivatives, including complex multicellular models such as organoids. iPS2-seq distinguishes true perturbation effects from genetic and epigenetic variability. It supports pooled and arrayed formats, integrates with microfluidic or split-pool single-cell RNA sequencing, and extends to multi-omic profiling of chromatin and proteins. A dedicated pipeline, catcheR, streamlines design and analysis. The platform enables stage-specific follow-up dissection of screen hits. We demonstrate this by targeting congenital heart disease-associated genes in monolayer cardiomyocytes and organoids. This reveals that epigenetic neuroectodermal priming interferes with germ layer differentiation in specific clones. Accounting for this bias, we show that SMAD2 controls cardiac progenitor specification, with knockdown redirecting cells toward fibroblast and epicardial fates. iPS2-seq unlocks rigorous functional genomics in hiPSC-based models.
    Keywords:  Functional Genomics; Human Pluripotent Stem Cells; Loss of Function; Pooled Screens; Single-cell RNA-seq
    DOI:  https://doi.org/10.1038/s44320-025-00172-8
  7. Orphanet J Rare Dis. 2025 Dec 10.
       BACKGROUND: The mTOR inhibitor Sirolimus was shown to improve symptoms in patients with slow-flow vascular malformations, but long-term continuous use is limited by cumulative toxicity. A personalized approach with intermittent regimens may offer similar efficacy with fewer adverse effects (AE). This retrospective analysis evaluated the effectiveness and safety of individualized sirolimus strategies in patients who experienced symptom recurrence after completing the 2-year course in the VASE phase III trial. All patients initially resumed continuous sirolimus for 3 months, then transitioned to one personalized regimen based on their pain profiles: intermittent sirolimus 5 days-ON/2 days-OFF (Group A), hybrid intermittent plus on-demand (Group B), or fully on-demand administration triggered by pain or known stressors (Group C).
    RESULTS: Thirty adults were included (Group A: n = 13; Group B: n = 6; Group C: n = 11). Across all groups, intermittent, hybrid or on-demand sirolimus maintained pain control comparable to continuous administration, significantly reducing pain intensity, crisis frequency, and crisis duration from baseline. AEs decreased from 73-85% during continuous therapy to 9-33% with intermittent/on-demand regimens, with no reported grade ≥3 event.
    CONCLUSION: Personalized intermittent sirolimus regimens may effectively control symptoms and substantially reduce toxicity in patients with vascular malformations. This strategy supports individualized, long-term therapy and merits prospective validation.
    TRIAL REGISTRATION: NCT02638389 and EudraCT 2015-001703-32.
    Keywords:  Adverse events; Intermittent; On-demand; Personalized regimen; Sirolimus; Slow-flow vascular malformation
    DOI:  https://doi.org/10.1186/s13023-025-04151-y
  8. Hum Genomics. 2025 Dec 09.
      Cerebral Cavernous Malformations (CCMs) are brain vascular lesions that occur in sporadic or inherited (autosomal dominant) forms. The malformations are driven by mutations in KRIT1, CCM2, PDCD10 or MAP3K3. Known oncogenic variants in PIK3CA accompany CCM-specific variants in lesions. While the primary genetic etiology of CCM lesions is relatively well understood, a subset of lesions does not yet have an identified molecular genetic etiology. Moreover, whether large genomic alterations occur somatically in CCM lesion tissue has been largely unexplored. In PIK3CA + cancers, large somatic copy number alterations ('CNAs') are frequent, with whole genome doubling and aneuploidy identified in most tumors. Such CNA events are known to be associated with course of disease and therapeutic response. In this study, using whole genome SNP-genotyping and Mosaic Chromosome Alteration (MoChA) analysis, we identify the presence of large (> 1 MB) somatic CNAs in CCMs, with specific enrichment of events in chromosome arms 16p,19p,17q, 20q. We also identify additional chromosome arm level events encompassing known CCM genes in a subset of lesions. Thus, we characterize a pattern of large genomic events that had remained hidden by the insensitivity of the molecular and analytical methods previously used. Finally, we propose that similar events may be found in other vascular malformations or PIK3CA overgrowth syndromes that have yet to be analyzed in this manner.
    DOI:  https://doi.org/10.1186/s40246-025-00886-8
  9. Nat Commun. 2025 Dec 12.
      CRISPR/Cas9 technologies provide unique capabilities for modeling disease and understanding gene-to-phenotype connections. In cultured cells, chemical-mediated control of Cas9 activity can limit off-target effects and enable mechanistic study of essential genes. However, widely-used Tet-On systems often show leaky Cas9 expression, leading to unintended edits, as well as weak activity upon induction. Leakiness can be problematic in the context of Cas9 nuclease activity, which may result in cumulative DNA damage and degradation of the target cell genome over time. To overcome these deficiencies, we have established transgenic platforms that minimize Cas9 functionality in the OFF-state along with maximized and uncompromised ON-state gene editing efficiency. By combining conditional destabilization and inhibition of Cas9, we have developed an all-in-one (one or multiple guide RNAs and Cas9) ultra-tight, Tet-inducible system with exceptional dynamic range (ON vs. OFF-state) across various cell lines and targets. As an alternative to Tet-mediated induction, we have created a Branaplam-regulated splice switch module for low-baseline and robust Cas9 activity control. Lastly, for circumstances where DNA damage needs to be avoided, we have constructed a dual-control, Tet-inducible CRISPRi module for tight and potent transcriptional silencing. This upgraded suite of inducible CRISPR systems has broad applications for numerous cell types and experimental conditions.
    DOI:  https://doi.org/10.1038/s41467-025-67201-w
  10. Hum Mol Genet. 2025 Dec 10. pii: ddaf185. [Epub ahead of print]
      Mutations in the PTEN gene have been implicated in autism spectrum disorders (ASD), particularly among individuals with comorbid macrocephaly. In our previous study, we demonstrated that the PTEN p.Ile135Leu variant, in an ASD-related genetic background dependent fashion, disrupts both cortical neurogenesis and gliogenesis. While abnormal cerebellar development is a recognized feature of ASD, the specific cellular targets and timing of disruptions during cerebellar differentiation and development remain poorly understood. To investigate these aspects, we applied our previously established cerebellar organoid protocol and used isogenic human iPSC lines harboring this PTEN-variant. We examined the expression of Purkinje cells, granule cells, interneurons, and glial cells prior to 22 weeks of differentiation, assessed genes expression at 8 weeks, and evaluated spontaneous spikes activity in Purkinje cells after 11 weeks. We observed that cell-type-specific expression patterns differed between the PTEN p.Ile135Leu variant in control versus ASD-genetic backgrounds. However, these background differences were diminished in PTEN knockout lines across both backgrounds. Our single-cell RNA sequencing (scRNA-seq) dataset revealed that the PTEN p.Ile135Leu variant increased the number of interneuron progenitor cells, whereas PTEN knockout led to an expansion of meningeal-like cells in both genetic contexts. Moreover, both the PTEN p.Ile135Leu variant and PTEN knockout abolished spontaneous simple spikes activity in Purkinje cells across both backgrounds, including PTEN-corrected patient-derived lines. Together, these findings provide direct evidence linking PTEN dysfunction and genetic background to altered cerebellar differentiation and neuronal network activity in human cerebellar organoids.
    Keywords:  Autism spectrum disorder; Cerebellar organoids; PTEN variant; Single cell RNA sequencing
    DOI:  https://doi.org/10.1093/hmg/ddaf185
  11. Nat Commun. 2025 Dec 12. 16(1): 10848
      The auxin-inducible degron (AID) system is designed for the rapid and near-complete degradation of a specific target protein in vivo. However, to understand the dynamics of complex physiological networks, researchers often need methods that produce graded, quantitative changes in degradation rates for multiple proteins simultaneously. Here, we develop the AID system for in vivo, quantitative control over the abundance of multiple proteins simultaneously. First, by measuring and modeling the on- and off-target activities of different AID system variants in Caenorhabditis elegans, we characterize a variant of the E3 ubiquitin ligase subunit TIR1, which provides improved degradation activity compared to the original AID and AID2 systems. Then, we develop a TIR1 expression construct that enables simultaneous pan-somatic and germline protein degradation. Finally, we expand the AID toolkit to allow independent, simultaneous degradation of two distinct tissue-specific proteins. Together, these technologies enable new in vivo approaches for studying quantitative cellular biology and organismal dynamics.
    DOI:  https://doi.org/10.1038/s41467-025-66347-x
  12. Genes Dev. 2025 Dec 11.
      Nutrient deficiency during pregnancy in many animal species can induce embryonic diapause, a state characterized by systemic changes in biosynthetic processes that minimize reliance on external energy sources while ensuring survival. Remarkably, these changes do not affect the pluripotent state of embryonic stem (ES) cells, allowing normal development once diapause ends. Here we identify a transcriptional mechanism that maintains ES cell pluripotency during diapause. We show that inhibition of mTOR, which induces a diapause-like state in ES cells, rapidly upregulates genes encoding negative regulators of the MAP kinase (NRMAPK) pathway, a key driver of ES cell differentiation. Elevated NRMAPK expression and associated suppression of MAP kinase activity are also hallmarks of ES cells driven into diapause-like states by long-term inhibition of BET proteins, which regulate differentiation- and growth-promoting gene expression. Suppression of NRMAPK in diapause-like ES cells leads to differentiation and termination of the diapause-like state. Mechanistically, diapause-associated NRMAPK activation involves mTOR or BET inhibition-triggered release of the transcriptional repressor Capicua (CIC) from NRMAPK gene promoters. Our data highlight a key role for mTOR- and BET-controlled transcriptional regulation of MAP kinase activity via negative regulators in maintaining the pluripotent state of diapause ES cells and potentially other metabolically dormant stem or stem-like cells.
    Keywords:  MAP kinase signaling; cell signaling; diapause; embryonic stem cell; epigenetics; mTOR signaling; nascent transcriptional changes; transcriptional regulation
    DOI:  https://doi.org/10.1101/gad.353143.125
  13. Nat Commun. 2025 Dec 06. 16(1): 10944
      Inflammation triggers systemic growth restrictions, a process well characterised in tumour cachexia. Whether inflammatory tissue damage also induces growth restrictions, and how regenerating tissue overcome them, is less explored. Using a tissue damage model in Drosophila, we identify metabolic and signaling adaptations that both induce and bypass systemic growth restrictions. Expression of eiger, the Drosophila TNF-α homolog, in imaginal discs causes systemic insulin restriction and insulin resistance, reducing protein translation and proliferation in peripheral tissues. Regenerating cells overcome this by upregulating Pdk1, which is necessary and sufficient to promote protein translation via an Insulin/Akt-independent mechanism. JAK/STAT acts upstream to elevate Pdk1, defining a JAK/STAT-Pdk1-S6K axis essential for regenerative proliferation. Regenerating cells also upregulate amino acid transporters and rely on mTORC1. Similar signatures in RasV12, scrib tumors indicate that tumors co-opt these pathways to sustain growth under insulin restriction. This physiological program thus integrates systemic nutrient mobilization and local metabolic reprogramming, with implications for tissue repair but also pathologies, such as chronic wounds and cancer.
    DOI:  https://doi.org/10.1038/s41467-025-66995-z
  14. Life Sci Alliance. 2026 Feb;pii: e202503529. [Epub ahead of print]9(2):
      The preparation of custom-made media offers precise control over nutrient composition, enabling detailed studies of cellular metabolism. We demonstrate how self-made media formulations enable diverse assay designs and readouts to assess cancer metabolism. Self-made media can be used in Seahorse assays to measure mitochondrial respiration under defined conditions. In nutrient deprivation experiments, amino acid or vitamin removal can uncover how cancer cells adapt to metabolic stress. Using labeled amino acids enables analysis of nascent protein synthesis and translational regulation, while stable-isotope tracing reveals metabolic fluxes through key pathways. This guide presents a suite of metabolic assays using custom-made media, covering experimental design, the selection of controls, sample preparation, data acquisition, and interpretation. The accompanying online media calculator "Media Minds" streamlines the creation of custom media formulations, ensuring accuracy and reproducibility.
    DOI:  https://doi.org/10.26508/lsa.202503529
  15. Mol Biol Evol. 2025 Dec 08. pii: msaf319. [Epub ahead of print]
      The insulin and insulin-like growth factor (IGF) system regulates essential biological functions such as growth, metabolism, and development. While its physiological roles are well characterized, the evolutionary origins and molecular diversification of its ligands and receptors remain incompletely defined. Here, we present the most comprehensive phylogenetic and sequence conservation analysis of this system to date, using over 1,000 sequences from vertebrates, invertebrates, and viruses. Our analyses reveal that insulin, IGF-1, and IGF-2 form distinct monophyletic clades that diverged after the emergence of vertebrates, with IGF-1 being the most conserved ligand. We show that IGF1R-binding residues, especially in the A- and B-domains of IGF-1, are highly conserved across vertebrates, while insulin's Site 2 residues, which overlap with its dimerization and hexamerization surface, are more variable-correlating with the loss of hexamer formation in hystricomorphs, reptiles, and jawless fish. Unexpectedly, we identify a 12-amino acid insert in the insulin receptor (IR) of turtles and tortoises, previously thought to be unique to mammalian IR-B isoform, challenging the view that receptor isoform diversity is a mammalian innovation. We also show that marsupials and monotremes retain ancestral receptor domain features shared with reptiles and birds, and that avian insulins, particularly A-chain residues, are unusually conserved. Viral insulin/IGF-like peptides (VILPs) fall into two distinct clades that resemble either IGFs or insulin. Together, these findings illuminate the evolutionary architecture of the insulin/IGF system, highlight unexpected lineage-specific adaptations, and provide a framework for understanding hormone-receptor function across biology and therapeutic design.
    DOI:  https://doi.org/10.1093/molbev/msaf319
  16. Nat Commun. 2025 Dec 11.
      Insulin/insulin-like growth factor signaling inhibits FOXO transcription factors to control development, homeostasis, and aging. Here, we use proximity labeling to identify proteins interacting with the C. elegans FOXO DAF-16. We show that in well-fed, unstressed animals harboring active insulin signaling, DAF-16 forms a complex with the PAR-1/MARK serine/threonine kinase, a key regulator of cell polarity. PAR-1 inhibits DAF-16 accumulation and promotes DAF-16 phosphorylation at S249, at a conserved motif that PAR-1/human MARK2 phosphorylates in vitro. DAF-2 insulin-like receptor signaling stimulates DAF-16 S249 phosphorylation, suggesting DAF-2 activates PAR-1. DAF-2 also promotes PAR-1 expression by inhibiting DAF-16. PAR-1 knockdown, or DAF-16 S249A, prolong lifespan, whereas phosphomimetic DAF-16 S249D suppresses the longevity of daf-2 mutants. At low insulin signaling, DAF-16 proximity labeling highlights transcription factors, chromatin regulators, and DNA repair proteins. One interactor, the zinc finger/homeobox protein ZFH-2/ZFHX3, forms a complex with DAF-16 and prolongs lifespan. Our work provides entry points for hypothesis-driven studies of FOXO function and longevity.
    DOI:  https://doi.org/10.1038/s41467-025-66409-0
  17. Redox Biol. 2025 Dec 04. pii: S2213-2317(25)00475-6. [Epub ahead of print]89 103962
      Coenzyme A (CoA) is an essential cellular cofactor and low molecular weight thiol (LMWT) that forms metabolically active thioesters involved in various metabolic pathways. Recently, CoA has emerged as an important antioxidant due to its covalent attachment to protein cysteine thiols in response to oxidative and metabolic stress. This modification, termed CoAlation, protects proteins from over-oxidation and can alter protein activity, subcellular localisation and conformation in eukaryotic and prokaryotic cells. However, whether protein CoAlation is implicated in cellular transformation or adaptation to oxidative stress in cancer cells is unknown. Cancer cells are known to harbour high basal reactive oxygen species (ROS) levels and to mitigate oxidative stress by deploying antioxidant enzymes and LMWTs, such as glutathione. Here we investigated whether CoAlation is a component of antioxidant responses in cancer cells. We found that protein CoAlation is detectable at basal levels and is also induced by oxidative stress in a range of cancer cell lines. Interestingly, much of this CoAlation occurs at the mitochondria. Levels of protein CoAlation can be modulated by inhibiting CoA and glutathione biosynthesis and are dependent on both cellular CoA and ROS levels. Deprivation of serum increases oxidative stress-induced protein CoAlation, indicating the requirement for growth and survival factors in antioxidant responses. In line with this, cells that are deficient in Insulin-like Growth Factor 1 (IGF-1) Receptor expression have higher ROS levels, express lower levels of antioxidant proteins, and have elevated levels of protein CoAlation. Overall, we conclude that protein CoAlation is an important arm of the antioxidant response, which is strongly integrated with and regulated by growth factor signalling and the broader antioxidant response.
    Keywords:  Antioxidant response; Cancer; Growth factor signalling; IGF-1R; Protein CoAlation; Reactive oxygen species
    DOI:  https://doi.org/10.1016/j.redox.2025.103962
  18. Nat Commun. 2025 Dec 08. 16(1): 10985
      The selection of cells that have acquired a desired gene edit is often done by the introduction of additional genes that confer drug resistance or encode fluorophores. However, such marker genes can have unintended physiological effects and are not compatible with editing of single nucleotides. Here, we present SNIPE, a method that allows the marker-free selection of edited cells based on single nucleotide differences to unedited cells. SNIPE drastically enriches for cells, which have been precisely edited (median 7-fold). We validate the approach for 42 different edits using Cas9 or Cas12a in different cell types and species. We use it to enrich for combinations of substitutions that change missense mutations carried by all people today back to the ancestral state seen in Neandertals and Denisovans. We also show that it can be used to kill cultured tumor cells with aberrant genotypes and to repair heterozygous tumorigenic mutations.
    DOI:  https://doi.org/10.1038/s41467-025-66896-1
  19. Nat Methods. 2025 Dec;22(12): 2585-2593
      Cells are a fundamental unit of biological organization, and identifying them in imaging data-cell segmentation-is a critical task for various cellular imaging experiments. Although deep learning methods have led to substantial progress on this problem, most models are specialist models that work well for specific domains but cannot be applied across domains or scale well with large amounts of data. Here we present CellSAM, a universal model for cell segmentation that generalizes across diverse cellular imaging data. CellSAM builds on top of the Segment Anything Model (SAM) by developing a prompt engineering approach for mask generation. We train an object detector, CellFinder, to automatically detect cells and prompt SAM to generate segmentations. We show that this approach allows a single model to achieve human-level performance for segmenting images of mammalian cells, yeast and bacteria collected across various imaging modalities. We show that CellSAM has strong zero-shot performance and can be improved with a few examples via few-shot learning. Additionally, we demonstrate how CellSAM can be applied across diverse bioimage analysis workflows. A deployed version of CellSAM is available at https://cellsam.deepcell.org/ .
    DOI:  https://doi.org/10.1038/s41592-025-02879-w